Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $169817.0.

  • Stemtech's Cost of Revenue fell 5533.54% to $169817.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $732101.0, marking a year-over-year decrease of 4269.25%. This contributed to the annual value of $1.3 million for FY2024, which is 3241.72% up from last year.
  • Latest data reveals that Stemtech reported Cost of Revenue of $169817.0 as of Q3 2025, which was down 5533.54% from $145909.0 recorded in Q2 2025.
  • In the past 5 years, Stemtech's Cost of Revenue registered a high of $447420.0 during Q4 2021, and its lowest value of $126980.0 during Q3 2021.
  • Over the past 5 years, Stemtech's median Cost of Revenue value was $262597.0 (recorded in 2022), while the average stood at $262064.1.
  • As far as peak fluctuations go, Stemtech's Cost of Revenue skyrocketed by 9856.83% in 2021, and later crashed by 5721.04% in 2025.
  • Quarter analysis of 5 years shows Stemtech's Cost of Revenue stood at $447420.0 in 2021, then dropped by 26.78% to $327609.0 in 2022, then plummeted by 32.92% to $219745.0 in 2023, then grew by 22.23% to $268593.0 in 2024, then tumbled by 36.78% to $169817.0 in 2025.
  • Its Cost of Revenue stands at $169817.0 for Q3 2025, versus $145909.0 for Q2 2025 and $147782.0 for Q1 2025.